These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32775213)

  • 1. False positive cases of elevated tetradecenoyl carnitine in newborn mass screening showed significant loss of body weight.
    Bo R; Awano H; Nishida K; Fujioka K; Nishiyama A; Miyake O; Iijima K
    Mol Genet Metab Rep; 2020 Sep; 24():100634. PubMed ID: 32775213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Using the C14:1/Medium-Chain Acylcarnitine Ratio Instead of C14:1 to Reduce False-Positive Results for Very-Long-Chain Acyl-CoA Dehydrogenase Deficiency in Newborn Screening in Japan.
    Tajima G; Aisaki J; Hara K; Tsumura M; Kagawa R; Sakura F; Sasai H; Yuasa M; Shigematsu Y; Okada S
    Int J Neonatal Screen; 2024 Feb; 10(1):. PubMed ID: 38390979
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnosis of very long chain acyl-dehydrogenase deficiency from an infant's newborn screening card.
    Wood JC; Magera MJ; Rinaldo P; Seashore MR; Strauss AW; Friedman A
    Pediatrics; 2001 Jul; 108(1):E19. PubMed ID: 11433098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Infants suspected to have very-long chain acyl-CoA dehydrogenase deficiency from newborn screening.
    Merritt JL; Vedal S; Abdenur JE; Au SM; Barshop BA; Feuchtbaum L; Harding CO; Hermerath C; Lorey F; Sesser DE; Thompson JD; Yu A
    Mol Genet Metab; 2014 Apr; 111(4):484-92. PubMed ID: 24503138
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biochemical and molecular characteristics among infants with abnormal newborn screen for very-long-chain acyl-CoA dehydrogenase deficiency: A single center experience.
    Upadia J; Noh G; Lefante JJ; Andersson HC
    Mol Genet Metab Rep; 2023 Dec; 37():101002. PubMed ID: 37671074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New Ratios for Performance Improvement for Identifying Acyl-CoA Dehydrogenase Deficiencies in Expanded Newborn Screening: A Retrospective Study.
    Wang B; Zhang Q; Gao A; Wang Q; Ma J; Li H; Wang T
    Front Genet; 2019; 10():811. PubMed ID: 31620161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical and biochemical outcome of patients with very long-chain acyl-CoA dehydrogenase deficiency.
    Rovelli V; Manzoni F; Viau K; Pasquali M; Longo N
    Mol Genet Metab; 2019 May; 127(1):64-73. PubMed ID: 31031081
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Newborn screening for carnitine palmitoyltransferase II deficiency using (C16+C18:1)/C2: Evaluation of additional indices for adequate sensitivity and lower false-positivity.
    Tajima G; Hara K; Tsumura M; Kagawa R; Okada S; Sakura N; Maruyama S; Noguchi A; Awaya T; Ishige M; Ishige N; Musha I; Ajihara S; Ohtake A; Naito E; Hamada Y; Kono T; Asada T; Sasai H; Fukao T; Fujiki R; Ohara O; Bo R; Yamada K; Kobayashi H; Hasegawa Y; Yamaguchi S; Takayanagi M; Hata I; Shigematsu Y; Kobayashi M
    Mol Genet Metab; 2017 Nov; 122(3):67-75. PubMed ID: 28801073
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lethal Undiagnosed Very Long-Chain Acyl-CoA Dehydrogenase Deficiency with Mild C14-Acylcarnitine Abnormalities on Newborn Screening.
    Spiekerkoetter U; Mueller M; Sturm M; Hofmann M; Schneider DT
    JIMD Rep; 2012; 6():113-5. PubMed ID: 23430948
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The natural history of elevated tetradecenoyl-L-carnitine detected by newborn screening in New Zealand: implications for very long chain acyl-CoA dehydrogenase deficiency screening and treatment.
    Ryder B; Knoll D; Love DR; Shepherd P; Love JM; Reed PW; de Hora M; Webster D; Glamuzina E; Wilson C
    J Inherit Metab Dis; 2016 May; 39(3):409-414. PubMed ID: 26743058
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Four Years' Experience in the Diagnosis of Very Long-Chain Acyl-CoA Dehydrogenase Deficiency in Infants Detected in Three Spanish Newborn Screening Centers.
    Merinero B; Alcaide P; Martín-Hernández E; Morais A; García-Silva MT; Quijada-Fraile P; Pedrón-Giner C; Dulin E; Yahyaoui R; Egea JM; Belanger-Quintana A; Blasco-Alonso J; Fernandez Ruano ML; Besga B; Ferrer-López I; Leal F; Ugarte M; Ruiz-Sala P; Pérez B; Pérez-Cerdá C
    JIMD Rep; 2018; 39():63-74. PubMed ID: 28755359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neonatal screening for very long-chain acyl-coA dehydrogenase deficiency: enzymatic and molecular evaluation of neonates with elevated C14:1-carnitine levels.
    Liebig M; Schymik I; Mueller M; Wendel U; Mayatepek E; Ruiter J; Strauss AW; Wanders RJ; Spiekerkoetter U
    Pediatrics; 2006 Sep; 118(3):1065-9. PubMed ID: 16950999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased acylcarnitine ratio indices in newborn screening for carnitine-acylcarnitine translocase deficiency shows increased sensitivity and reduced false-positivity.
    Shi C; Ao Z; Liu B; Xiao X; Gu X; Yang Q; Hao H; Cai Y; Li S
    Transl Pediatr; 2023 May; 12(5):871-881. PubMed ID: 37305732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum C14:1/C12:1 ratio is a useful marker for differentiating affected patients with very long-chain acyl-CoA dehydrogenase deficiency from heterozygous carriers.
    Yamada K; Osawa Y; Kobayashi H; Hasegawa Y; Fukuda S; Yamaguchi S; Taketani T
    Mol Genet Metab Rep; 2019 Dec; 21():100535. PubMed ID: 31844625
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Newborn screening program and blood amino acid profiling in early neonates with citrin deficiency].
    Tang CF; Liu SC; Feng Y; Mei HF; Liu HP; Feng JW; Ye LX; Wang GQ; Liu L; Huang YL
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):797-801. PubMed ID: 31594068
    [No Abstract]   [Full Text] [Related]  

  • 16. Dissection of biochemical borderline phenotypes in carriers and genetic variants of medium-chain acyl-CoA dehyrogenase deficiency: implications for newborn screening [corrected].
    Maier EM; Pongratz J; Muntau AC; Liebl B; Nennstiel-Ratzel U; Busch U; Fingerhut R; Olgemöller B; Roscher AA; Röschinger W
    Clin Genet; 2009 Aug; 76(2):179-87. PubMed ID: 19780764
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A heterozygous missense mutation in adolescent-onset very long-chain acyl-CoA dehydrogenase deficiency with exercise-induced rhabdomyolysis.
    Hisahara S; Matsushita T; Furuyama H; Tajima G; Shigematsu Y; Imai T; Shimohama S
    Tohoku J Exp Med; 2015 Apr; 235(4):305-10. PubMed ID: 25843429
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Newborn Screening with (C16 + C18:1)/C2 and C14/C3 for Carnitine Palmitoyltransferase II Deficiency throughout Japan Has Revealed C12/C0 as an Index of Higher Sensitivity and Specificity.
    Tajima G; Hara K; Tsumura M; Kagawa R; Sakura F; Sasai H; Yuasa M; Shigematsu Y; Okada S
    Int J Neonatal Screen; 2023 Oct; 9(4):. PubMed ID: 37987475
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Very Long-Chain Acyl-CoA Dehydrogenase Deficiency: High Incidence of Detected Patients With Expanded Newborn Screening Program.
    Remec ZI; Groselj U; Drole Torkar A; Zerjav Tansek M; Cuk V; Perko D; Ulaga B; Lipovec N; Debeljak M; Kovac J; Battelino T; Repic Lampret B
    Front Genet; 2021; 12():648493. PubMed ID: 33986768
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Misclassification of VLCAD carriers due to variable confirmatory testing after a positive NBS result.
    Atkins AE; Tarini BA; Phillips EK; Calhoun ARUL
    J Community Genet; 2019 Oct; 10(4):447-451. PubMed ID: 30721391
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.